[6-K] Prenetics Global Ltd Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Prenetics Global Limited reported that its Chief Marketing Officer, Rahul Ramchand, purchased 30,000 Class A Ordinary Shares in the open market on November 12, 2025 at $13.17 per share, for a total of $395,151. Following this transaction, his holdings increased to 45,553 Class A Ordinary Shares.

The purchase was disclosed via a Form 6-K and reflects an executive open-market buy.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number 001-41401

Prenetics Global Limited

11401 Granite St. Charlotte, NC 28273 USA Unit 703-706, K11 Atelier 728 King’s Road, Quarry Bay Hong Kong

(Addresses of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.  Form 20-F  Form 40-F 

EXPLANATORY NOTE

Prenetics Global Limited (the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, furnishes this Form 6-K to announce that on November 12, 2025 its Chief Marketing Officer, Rahul Ramchand, purchased 30,000 shares of the Company's Class A Ordinary Shares at a price of $13.17 per share in the open market for a total purchase price of $395,151, bringing his total holdings to 45,553 Class A Ordinary Shares.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			Prenetics Global Limited
			By:			/s/ Lo Hoi Chun
			Name:			Lo Hoi Chun
			Title:			Chief Financial Officer
Date: November 13, 2025